Adaptimmune Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. 

CEO
Adrian Rawcliffe
CEOAdrian Rawcliffe
Employees
449
Employees449
Headquarters
Abingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded
2008
Founded2008
Employees
449
Employees449

ADAP Key Statistics

Market cap
285.11M
Market cap285.11M
Price-Earnings ratio
-3.21
Price-Earnings ratio-3.21
Dividend yield
—
Dividend yield—
Average volume
1.22M
Average volume1.22M
High today
$1.19
High today$1.19
Low today
$1.09
Low today$1.09
Open price
$1.17
Open price$1.17
Volume
1.52M
Volume1.52M
52 Week high
$2.05
52 Week high$2.05
52 Week low
$0.42
52 Week low$0.42

Analyst ratings

70%

of 10 ratings
Buy
70%
Hold
20%
Sell
10%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.